Scopia Capital Management LP United Therapeutics Corp Transaction History

Scopia Capital Management LP

  • $675 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $48.5 Million - $57.9 Million
-269,455 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $10.3 Million - $12.8 Million
60,170 Added 28.75%
269,455 $48.3 Million
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $578,660 - $657,261
3,759 Added 1.83%
209,285 $35 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $20.9 Million - $31.2 Million
205,526 New
205,526 $31.2 Million

Others Institutions Holding UTHR

# of Institutions
641
Shares Held
45.2M
Call Options Held
368K
Put Options Held
410K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Scopia Capital Management LP Portfolio

Follow Scopia Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scopia Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Scopia Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email